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The breast cancer susceptibility protein, BRCA2, is
essential for recombinational DNA repair. BRCA2
delivers RAD51 to double-stranded DNA (dsDNA)
breaks through interaction with eight conserved,
35 amino acid motifs, the BRC repeats. Here we
show that the solitary BRC4 promotes assembly of
RAD51 onto single-stranded DNA (ssDNA), but not
dsDNA, to stimulate DNA strand exchange. BRC4
acts by blocking ATP hydrolysis and thereby main-
taining the active ATP-bound form of the RAD51-
ssDNA filament. Single-molecule visualization shows
that BRC4 does not disassemble RAD51-dsDNA
filaments but rather blocks nucleation of RAD51
onto dsDNA. Furthermore, this behavior is mani-
fested by a domain of BRCA2 comprising all eight
BRC repeats. These results establish that the BRC
repeats modulate RAD51-DNA interaction in two
opposing but functionally reinforcing ways: targeting
active RAD51 to ssDNA and prohibiting RAD51
nucleation onto dsDNA. Thus, BRCA2 recruits
RAD51 to DNA breaks and, we propose, the BRC
repeats regulate DNA-binding selectivity.
INTRODUCTION
Thebreast cancer susceptibility gene,BRCA2, encodes aprotein
of 3418 amino acids (Wooster et al., 1995). BRCA2 is needed for
DNA repair by homologous recombination (Moynahan et al.,
2001; Tutt et al., 2001), the predominant mechanism employed
by cells to accurately repair double-strand breaks (DBSs). The
inability to purify full-length BRCA2 protein has hampered anal-
ysis of its role in this essential biological process. However, crys-
tallographic studies revealed that BRCA2 possesses both
a DNA-binding domain (DBD), with unique structural features
for binding ssDNA and dsDNA (Yang et al., 2002), and BRC
repeats, which bind to the core of RAD51 bymimicking the struc-
ture of an adjacent RAD51 monomer (Pellegrini et al., 2002).
Electron microscopy uncovered two different loci for binding to
RAD51, the N-terminal domain and the nucleotide-binding core1032 Cell 136, 1032–1043, March 20, 2009 ª2009 Elsevier Inc.(Galkin et al., 2005). In addition, another RAD51-binding site
was mapped to the C terminus of BRCA2 (Esashi et al., 2007).
Together, these results suggest that the intact BRCA2 protein
might bind both DNA and RAD51 and deliver RAD51 to the sites
of DNA breaks (Kowalczykowski, 2005; Pellegrini et al., 2002;
Shin et al., 2003; Yang et al., 2002).
The importance of the BRC motifs to BRCA2 function in the
maintenance of genome integrity is supported by observations
showing that point mutations within BRC that compromise
interactions with RAD51 are found in individuals predisposed
to breast cancer (Breast Cancer Information Core, http://
research.nhgri.nih.gov/bic/). At least one BRC repeat, in
concert with the DBD of BRCA2, is required for targeting
RAD51 to ssDNA (San Filippo et al., 2006). Moreover, a fusion
of a BRC repeat with the large subunit of the human ssDNA-
binding protein, Replication protein-A (RPA), is sufficient to
suppress cellular defects found in brca2 mutant mammalian
cells (Saeki et al., 2006). In fact, exogenous expression of
mutants deleted for the BRC repeats or with missense muta-
tions that give rise to familial cancers eliminates the ability of
BRCA2 to restore resistance to methyl methanesulphonate
(MMS) (Chen et al., 1998). However, apparently contradictory
effects reported for the BRC repeats on RAD51 behavior have
confounded molecular understanding of their function. For
instance, BRC repeats are reported to both block assembly of
the RAD51 nucleoprotein filament on dsDNA and paradoxically
stabilize the same nucleoprotein filament (Chen et al., 1999;
Davies et al., 2001; Galkin et al., 2005; Shivji et al., 2006). These
seemingly disparate observations may simply reflect experi-
mental differences among the various studies, or instead they
may suggest an unappreciated complexity in the mechanism
by which the BRC repeats regulate RAD51 function. Here we
use ensemble- and single-molecule methods to examine the
effects of the BRC4 repeat on RAD51 nucleoprotein filament
assembly on both ssDNA and dsDNA. We uncover a dichotomy
with regard to the effect of BRC4 and a BRCA2 domain
including the eight repeats, BRCA2BRC1–8, on these two types
of DNA: BRC4 and BRCA2BRC1–8 stabilize filament formation
on ssDNA but prevent filament formation on dsDNA. The conse-
quence of this control over DNA selection results in an enhance-
ment of the DNA strand exchange activity of RAD51 protein by
the BRC repeats that we propose is a function within the intact
BRCA2 protein.
Figure 1. Stimulation of RAD51-ssDNA Complex Formation by BRC4 and BRCA2BRC1–8
(A) Gel showing RAD51 (3 mM) incubated with either GST-BRC4 or GST-D1524–30 prior to incubation with 32P-labeled dT40 ssDNA (0.3 mM) for 1 hr in the
presence of ATP, Mg2+, and Ca2+.
(B) Quantification of protein-DNA complexes with GST-BRC4 (filled circles) or GST-D1524–30 (open circles) obtained as in (A), using ATP, Mg2+ + Ca2+
(black circle); ATP and Mg2+ (yellow circle); ADP, Mg2+ + Ca2+ (green circle), ATP and Ca2+ (red circle); AMP-PNP, Mg2+ + Ca2+ (purple circle); or no nucleotide
cofactor, Mg2+ + Ca2+ (blue circle). Data obtained with the control mutant, GST-T1526A, ATP, Mg2+ + Ca2+ (blue square).
(C) BRC4 forms a stoichiometric complex with RAD51-ssDNA complexes. RAD51 (0.15 mM) was incubated with BRC4 (red circle) or BRCA2BRC1–8 (purple circle),
or RAD51 (0.3 mM) was incubated with BRC4 (black circle), prior to incubation with 32P-labeled dT40 ssDNA (15 nM) for another 15 min in the presence of ATP,
Mg2+, and Ca2+. Due to limitations of the protein stock, higher BRCA2BRC1–8 concentrations could not be examined.
(D) BRC4 increases the stability of RAD51-ssDNA complexes to increasing salt concentrations; complexes were formed with RAD51 (0.9 mM) alone (upper panel)
or RAD51 (0.9 mM) and GST-BRC4 (3.6 mM) (lower panel), in the presence of ADP and Mg2+.
Error bars represent the standard deviation (SD) from at least three independent experiments.RESULTS
BRC4 and BRCA2BRC1–8 Stimulate the Formation
of RAD51 Nucleoprotein Filaments on ssDNA
Because prior studies had not specifically focused on the role of
BRC repeats in RAD51 nucleoprotein filament on ssDNA, we
decided to first examine the effect of the well-characterized
BRC4 repeat (Pellegrini et al., 2002) on the assembly of
RAD51 onto ssDNA. BRC4 was purified as a fusion with gluta-
thione-S-transferase (GST); as controls, a GST-fused repeat
with a deletion, D1524–30, and a GST-fused repeat with a point
mutation, T1526A (Figure S1 available online), each of which fails
to bind RAD51 (Chen et al., 1999; Davies et al., 2001) (confirmed
using a GST pull-down assays; data not shown), were also
purified. For the ssDNA, to avoid the ambiguity introduced bydsDNA that results from secondary structure forming within
native ssDNA, the homopolymer, dT40, was initially used.
BRC4 was incubated with RAD51, ssDNA added, and then the
complexes were analyzed using electrophoretic mobility shift
assays (EMSA). As expected, BRC4 alone does not bind the
ssDNA (Figure 1A, lane 1). In the presence of ATP, the RAD51
nucleoprotein filaments are partially stable and only 30% of
the DNA is shifted (Figure 1A, lane 2). The addition of BRC4
unexpectedly produced a BRC4 concentration-dependent
increase in RAD51-ssDNA complexes from 30% to almost
100% (lanes 3–8), whereas the control peptides, D1524–30
(lanes 9 and 10 and Figure 1B) or T1526A (Figure 1B), had
no effect. Maximum stimulation occurred at about 12 mM of
peptide and then declined at higher concentrations of BRC4
(Figures 1A–1C).Cell 136, 1032–1043, March 20, 2009 ª2009 Elsevier Inc. 1033
The EMSA in Figure 1A was obtained using a mixture of Ca2+
and Mg2+, which resulted in better defined RAD51-ssDNA
complexes due to their greater kinetic stability imparted by the
Ca2+ (Bugreev and Mazin, 2004). However, even when Ca2+
was omitted, BRC4 stabilized the RAD51 nucleoprotein filament
(Figure 1B, ‘‘ATP (Mg2+)’’). BRC4 also increased RAD51-ssDNA
complex formation when either dT60 or dT70 were used (data
not shown). When an oligonucleotide with a random 26 nucleo-
tide sequence was used, nucleoprotein complex formation
was stimulated by BRC4 from 3% to 15%; the use of longer
mixed sequence DNA resulted in complex formation with
RAD51 that involved more than 75% of the DNA, precluding
detection of stimulation by BRC4 (data not shown). The pres-
ence of the GST tag did not affect the results, as an untagged
BRC4 peptide also stimulated binding (Figure S2). When the
concentrations of RAD51 were reduced (10- and 20-fold), both
the profile and optimum for stimulation by BRC4 were propor-
tionally shifted (Figure 1C), indicating that the stimulatory effect
of BRC4 is the consequence of forming a defined complex
with RAD51 and not a nonspecific effect (Davies et al., 2001;
Galkin et al., 2005); at these lower concentrations, the binding
of BRC4 to RAD51 is not stoichiometric, requiring excess
amounts of BRC4 to drive binding to RAD51. To confirm that
these effects were not unique to the BRC4 repeat, a domain
corresponding to all eight of the BRC repeats, BRCA2BRC1–8,
was examined (Shivji et al., 2006). A similar profile of stimulation
was observed with BRCA2BRC1–8; due to limitations of the
protein stock, higher BRCA2BRC1–8 concentrations could not
be examined (Figure 1C). This finding shows that the BRC4
repeat and BRCA2BRC1–8 behave similarly.
Interestingly, either when Ca2+ replaced the Mg2+ to prevent
the hydrolysis of ATP (Bugreev and Mazin, 2004) or when the
nonhydrolyzable analog, AMP-PNP, was used, BRC4 did not
stimulate the binding of RAD51 to ssDNA but rather inhibited
filament formation (Figure 1B). These results suggest that the
stabilization of nucleoprotein filaments by BRC4 requires ATP
hydrolysis by the nucleoprotein filament. Finally, BRC4 appeared
to have little or no effect when ATP was replaced by ADP
(Figure 1B) but, because the ADP-complex is more stable than
the ATP-bound form (Kim et al., 2002; unpublished data), this
increased stability precluded detection of a stabilizing effect.
Therefore, to measure the effect of BRC4 on ADP-RAD51-
ssDNA complexes, we examined the dissociation of these
complexes due to elevated salt concentrations. Figure 1D shows
that BRC4 increased the stability of the ADP-RAD51-ssDNA
complexes against dissociation at high NaCl concentrations.
Thus, BRC4 stabilizes RAD51-ssDNA filaments only when
hydrolysis of ATP to ADP is permitted, or when ADP is present
initially.
BRC4 Prevents ssDNA-Dependent ATP Hydrolysis
by RAD51, thereby Maintaining the Active
ATP-Bound Form of the Filament
To understand the mechanism by which BRC4 stabilizes
RAD51-ssDNA complexes, we explored the effect of BRC4 on
the ssDNA-dependent ATPase activity of RAD51. BRC4 reduced
ATP hydrolysis by RAD51 for all the ssDNA examined, both
homopolymers and natural DNA (Figure 2A). In the absence of1034 Cell 136, 1032–1043, March 20, 2009 ª2009 Elsevier Inc.BRC4, the rate of ATP hydrolysis was fastest for the shorter
ssDNA due, likely, to the more dynamic nature of the filaments
on shorter DNA. In all cases, BRC4 reduced the hydrolysis rate
to the DNA-independent rate, while the control peptide had no
effect (Figure 2A). This inhibition of ATP hydrolysis was not due
to dissociation of the nucleoprotein filaments since BRC4 stabi-
lized the complexes under these conditions (Figure 1). Finally,
BRC4 also inhibited similarly the ATPase activity of RAD51
when RPA was present (Figure S3), showing that the effects of
BRC4 are not altered by RPA.
Because BRC4 could prevent ATP hydrolysis at a number of
different steps in the ATP hydrolysis cycle (e.g., by blocking
ATP binding, ADP dissociation, or the catalytic step), we sought
to determine which nucleotide was bound to the BRC4-inhibited
filament. To determine whether BRC4 affected the proportion of
ATP and ADP bound to the RAD51 nucleoprotein, we used
a modified version of an assay described previously (Bugreev
and Mazin, 2004). Nucleoprotein filaments were formed in the
presence of [a-32P] ATP, isolated from free nucleotides, and
then the nucleotide (ATP/ADP) composition of the filament was
measured (Figures 2B–2D). BRC4 reduced the fraction of ADP
bound and concomitantly increased the amount of ATP bound
to nucleoprotein filaments formed on either dT40 (Figure 2B,
upper panel) or fX174 ssDNA (Figure 2B, lower panel). The rela-
tive increase in amount of nucleotide-bound (for both ATP and
ADP) complexes (4-fold for dT40 and more than 10-fold for
fX174 ssDNA) correlates with the stabilization of the ssDNA
complexes shown in Figure 1. More significantly, in the presence
of BRC4, the resulting filaments contain nearly 100% ATP
(Figure 2D). These results provide direct evidence that BRC4
permits accumulation of the active, ATP-bound form of
RAD51-ssDNA filament. Moreover, since BRC4 both stimulates
the assembly of RAD51 onto ssDNA only when ATP hydrolysis is
occurring (Figure 1B) and stabilizes the ADP-RAD51-ssDNA
complex, these findings strongly suggest that BRC4 acts by
preventing dissociation of ADP-RAD51 from ssDNA, permitting
exchange of ATP for ADPwithin the filament, and finally blocking
ATP hydrolysis. The consequence of these events is formation
and preservation of the active ATP-RAD51-ssDNA nucleoprotein
filament.
BRC4 and BRCA2BRC1–8 Prevent the Formation
of RAD51 Nucleoprotein Filaments on dsDNA
Given that RAD51 can bind both ssDNA and dsDNA (Baumann
et al., 1996;Mazin et al., 2000), but only the ssDNA nucleoprotein
filament is functional (Sung and Robberson, 1995), we next
investigated the effect of BRC4 on the binding of RAD51 to
dsDNA. RAD51 was incubated with increasing concentrations
of BRC4 prior to addition of 32P-labeled fX174 linear dsDNA
(Figure 3). As expected, BRC4 alone did not bind dsDNA
(Figure 3A, lane 1). However, in the presence of ATP, increasing
concentrations of BRC4 inhibited binding of RAD51 to dsDNA,
which is opposite to the behavior seen with ssDNA. The control
peptides, D1524–30 and T1526A, did not prevent RAD51-
dsDNA filament formation (Figure 3A, lanes 9 and 10, and
Figure 3B). As with ssDNA binding, the GST tag did not affect
the results since an untagged BRC4 peptide had the same effect
(Figure S4A). The same outcome was obtained when fX174
Figure 2. BRC4 Inhibits ATP Hydrolysis and Permits Accumulation of ATP-Bound RAD51-ssDNA Filaments
(A) BRC4 reduces the rate of ATP hydrolysis by RAD51. RAD51 (3 mM) was incubated with increasing concentrations of GST-BRC4 (filled circles) or the control
peptide GST-D1524–30 (open circles), as indicated, prior to addition of dT40 (black circle), dT60 (purple circle), dT90 (blue circle), M13 ssDNA (green circle), or
fX174 ssDNA (orange circle) and further incubated for 1 hr in the presence of 0.5 mM ATP and 4 mM Mg2+. The dashed line represents the DNA-independent
rate of ATP hydrolysis by RAD51 (0.2 mM/min).
(B) Nucleotides bound to purified nucleoprotein filaments as a function of BRC4 concentration as measured by TLC.
(C) Amount of total nucleotide (ATP + ADP) bound to the RAD51-ssDNA complex formed with either dT40 (black circles) or fX174 ssDNA (orange circles) in pres-
ence of GST-BRC4 (filled circles) or GST-D1524–30 (open circles), relative to the amount in the absence of BRC4.
(D) Percentages of ATP (solid lines) and ADP (dashed lines) in the RAD51 nucleoprotein filaments formed on dT40 (black circles) or fX174 ssDNA (orange circles).
Error bars represent the SD from at least three independent experiments and, in some cases, are smaller than the symbol.dsDNA was substituted with a shorter duplex DNA, dT40$dA40
(Figure 3C), and when BRCA2BRC1–8 was employed instead of
BRC4 (Figure 3D). When Ca2+ was substituted for Mg2+, BRC4
still inhibited binding of RAD51 to dsDNA (Figure S4B). But
when AMP-PNP was used instead of ATP, BRC4 did not inhibit
RAD51 nucleoprotein filament formation (Figure 3B). The obser-
vation that BRC4 does not block RAD51-dsDNA binding in the
presence of AMP-PNP but does so in the presence of ATP and
Ca2+ suggests that there is a difference in the structural confor-
mation adopted by the BRC4-RAD51 filament that is dependent
on the type of nucleotide cofactor and DNA. Previously, the
amino-terminal domain of RAD51 in dsDNA filaments was found
to become dynamic when ATP was used instead of AMP-PNP
(Galkin et al., 2005), and this structural flexibility suggests that
BRC4 acts to destabilize the RAD51-dsDNA filament through
a conformation state that is accessible only when the physiolog-
ical cofactor ATP is present.
The BRC Repeats Prevent Nucleation of RAD51 onto
dsDNA but Do Not Disrupt a RAD51-dsDNA Filament
To understand the basis for the inhibition of RAD51-dsDNA
complex formation by BRC4, we examined RAD51-dsDNAnucleoprotein filaments at the single-molecule level. A fluores-
cently labeled RAD51 protein (Hilario et al., 2008) was used to
visualize RAD51 filament formation on dsDNA following
a strategy reported previously for RecA protein (Galletto et al.,
2006). Briefly, a flow cell was used to generate three separate
laminar flow channels (Figure 4A). In the capture channel (step
1), a biotinylated bacteriophage l DNA molecule, stained with
the fluorescent intercalating dye, YOYO-1, and attached to
a streptavidin-coated bead, was optically trapped. The bead-
YOYO-1-DNA complex was then moved into the observation
channel under conditions that dissociate the dye from DNA
(step 2). This dye-free DNA was subsequently moved to the
protein channel containing the fluorescently modified RAD51,
alone, with BRC4, or with D1524–30 (step 3). After incubation
for the specified times in the presence of ATP and Ca2+, the
trapped DNA was moved into the observation channel (step 4)
where the bound fluorescent-RAD51 was visualized.
An example of a RAD51 filament formed by successively
‘‘dipping’’ a single dsDNA molecule in the protein channel for
20 or 30 s is shown in Figure 4B, left panel: within 20 s, RAD51
was seen along much of the dsDNA, and nucleoprotein filament
formation was nearly complete in 60 s. In marked contrast, a 4:1Cell 136, 1032–1043, March 20, 2009 ª2009 Elsevier Inc. 1035
Figure 3. BRC4 and BRCA2BRC1–8 Block RAD51-dsDNA Complex Formation
(A) Autoradiograph of an agarose gel showing RAD51 (3 mM) incubated with either GST-BRC4 or GST-D1524–30 prior to incubation with 32P-labeled fX174 linear
dsDNA (5 mM, nt) and further incubation for 1 hr in the presence of ATP, Mg2+, and Ca2+.
(B) Quantification of data as in (A): in the presence of ATP, Mg2+ + Ca2+ (black circle); ADP, Mg2+ + Ca2+ (green circle); ATP and Ca2+ (red circle); or AMP-PNP,
Mg2+ + Ca2+ (purple cirlce). Filled circles and solid lines correspond to GST-BRC4; open circles and dashed lines correspond to GST-D1524–30. Data obtained
with the control mutant, GST-T1526A, in the presence of ATP, Mg2+ + Ca2+ (blue square).
(C) The effect of BRC4 or BRCA2BRC1–8 on RAD51-dsDNA complex formation using dA40$dT40 dsDNA. RAD51 (0.15 mM) was incubated with GST-BRC4 or
BRCA2BRC1–8, at the concentrations indicated prior to incubation with
32P-labeled dA40$dT40 dsDNA (2.4 mM, nt) and further incubation for 1 hr in the presence
of ATP, Mg2+, and Ca2+. Protein-DNA complexes were resolved in 6% PAGE and analyzed by autoradiography.
(D) Data obtained as in (C), quantified and plotted in the presence of: GST-BRC4 (black circle); BRCA2BRC1-8 (purple triangle).
Error bars represent the SD from at least three independent experiments and, in some cases, are smaller than the symbol.molar ratio of BRC4 nearly eliminated nucleoprotein filament
nucleation (Figure 4B, middle panel): a mean of 1.5 ± 1.4 nucle-
ation events were visible after 180 s (nucleation rate = 0.50 ± 0.46
min1) (Figure 4D). At the same concentration, the control
D1524–30 peptide had no effect (Figure 4B, right panel). These
single-molecule results agree fully with our ensemble experi-
ments (Figure S4B).
The RAD51 nucleation frequency was seen to depend on
BRC4 concentration (Figure 4D): when reduced to 1:1
(BRC4:RAD51), nucleation was still low (1.7 ± 0.3 min1), but
upon further reduction to 0.5:1, the rate increased to 22 ±
3.8 min1 (Figures 4C and 4D). At the two concentrations tested,
0.5:1 and 2:1 (BRCA2BRC1–8:RAD51), the effect of BRCA2BRC1–8
on the RAD51 nucleation rate was found to be comparable to
that of BRC4 (Figures 4C and 4D), substantiating the results
obtained with a single BRC repeat. In the absence of BRC4 or
BRCA2BRC1–8, nucleation was too rapid to measure reliably.
The effect of increasing peptide concentration on nucleus forma-1036 Cell 136, 1032–1043, March 20, 2009 ª2009 Elsevier Inc.tion is summarized in Figure 4E; maximal inhibition of nucleation
occurred at an approximately equimolar ratio of BRC4 or
BRCA2BRC1–8 to RAD51.
We next examined whether BRC4 can disrupt preformed
RAD51-dsDNA filaments. RAD51 nucleoprotein filaments were
formed in the protein channel as was done for the assembly
experiments, except Mg2+ was used instead of Ca2+ to permit
ATP hydrolysis and subsequent dissociation. Once the filament
was fully extended (4 min in these conditions), the DNA was
moved to the second channel containing both Mg2+ and ATP
to commence disassembly. Within experimental error, when
BRC4 was present in the second channel, the rate of disas-
sembly of the preformed fluorescent RAD51-dsDNA filaments
was unchanged (Figure 5A). The DNA length is proportional to
the amount of RAD51 bound (Hilario et al., 2008); hence,
measurement of the DNA length as a function of time permits
quantification of the first order rate constant for dissociation.
In the presence of BRC4, RAD51 disassembles at a rate of
Figure 4. Single-Molecule Visualization Reveals that BRC4 and BRCA2BRC1–8 Inhibit Nucleation of RAD51 on dsDNA
(A) Schematic representation of the experiment. The bead-DNA-YOYO-1 complex is trapped (step 1) and then washed to dissociate YOYO-1 (step 2). The lDNA
is incubated in the protein channel with fluorescently labeled RAD51, 1 mM ATP, 2 mM Ca(OAc)2, and the indicated amount of peptide (step 3). The resulting
RAD51 filament is moved back to the observation channel for analysis (step 4).
(B) Temporal series of images showing RAD51 nucleoprotein filament assembly on one DNAmolecule. From left to right: filament formation by RAD51 alone, with
GST-BRC4 and with GST-D152–30, respectively, at 4:1 molar ratio (peptide:RAD51) or (C) 2:1 and 0.5:1 ratios using BRC4 or BRCA2BRC1–8.
(D) Cluster appearance as a function of time on lDNA after incubation with 250 nMRAD51 and 1 mM (red circle), 0.5 mM (green circle), 250 nM (orange circle), and
125 nM (blue circle) GST-BRC4 or 0.5 mM (purple triangle) and 125 nM (purple square) BRCA2BRC1–8. The dashed lines represent the linear regressions of the data.
(E) Rate of cluster formation versus BRC4 or BRCA2BRC1–8 concentration; each time point is the average of 4–9 individual molecules analyzed as in (D).
Error bars indicate SD and, in some cases, are smaller than the symbols.0.14 (±0.05) mmmin1; in its absence, the rate is 0.17 (±0.09) mm
min1 (Figure 5B). These data, both the visual presence of fluo-
rescent RAD51 and the nucleoprotein length, demonstrate that
BRC4 does not accelerate disassembly of the RAD51-dsDNA
filament.
BRC4 Can Stimulate RAD51-Mediated DNA Strand
Exchange
Together, the ensemble- and single-molecule experiments
indicate that BRC4 stabilizes the ATP-RAD51-ssDNA filamentbut blocks filament formation on dsDNA at the nucleation level.
Therefore, we reasoned that BRC4 should also stimulate
RAD51-mediated DNA strand exchange by both promoting fila-
ment assembly on ssDNA and preventing inhibitory filament
formation on the target dsDNA. To test this prediction, we exam-
ined DNA strand exchange activity in the presence of RPA
(Figure 6A). Initially, optimal conditions employing a stoichio-
metric amount of RAD51 relative to ssDNA were used (Benson
et al., 1994; Bugreev and Mazin, 2004; Sung and Robberson,
1995). As expected, at these conditions (Figures 6B, left panelCell 136, 1032–1043, March 20, 2009 ª2009 Elsevier Inc. 1037
and 6C) RAD51 promoted the formation of DNA strand exchange
products, joint molecules, and nicked circular dsDNA. At these
conditions, BRC4 showed a negligible stimulation of product
formation compared to the control D1524–30 peptide, although
BRC4 did inhibit product formation at high concentrations
(Figures S5A and S5B) due to inhibition of RAD51 binding to
the fX174 ssDNA at these higher BRC4 concentrations (data
not shown; see Figure 1C). However, it is well known that
when the RAD51 concentration exceeds the stoichiometric
optimum with regard to ssDNA, RAD51 self-inhibits DNA strand
Figure 5. BRC4 Does Not Promote the Disassembly of RAD51-dsDNA Filaments
(A) Temporal series of images showing disassembly of a RAD51 (250 nM) nucleoprotein filament with 2 mM Mg(OAc)2 and 1 mM ATP in all channels: left panel,
RAD51; right panel, RAD51 with GST-BRC4 (1 mM).
(B) Time dependence of filament dissociation after incubation with RAD51 alone (black) or with GST-BRC4 (red). Each time point is the average of 3–4 individual
molecules, and the lines represent fits of the data to a single exponential decay. The dotted line represents the starting length of the naked l DNA.
Error bars indicate SD of the observed length of the individual molecules measured.Figure 6. BRC4 Stimulates RAD51-Mediated DNA Strand Exchange
(A) Diagramof DNA strand exchange between circular ssDNA and homologous linear dsDNA to produce jointmolecules (JM) and nicked circular dsDNA (NC). The
asterisk shows the 32P-label on each strand.
(B) Effect of GST-BRC4 or the control peptides GST-D1524–30 and GST-T1526A on DNA strand exchange between fX174 circular ssDNA and linear dsDNA
promoted by RAD51 protein at 7.5 mMRAD51 (right panel); the uneven substrate bands resulted from a drying artifact. The left panel shows DNA strand exchange
products at the optimal RAD51 concentration (3.75 mM). Size markers (kb) are shown in the left lane.
(C) Quantification of the jointmolecules (red) and nicked circular dsDNA (black) products using 3.75 mMRAD51 (inverted triangles); 7.5 mMRAD51 andGST-BRC4
(filled circles); 7.5 mM RAD51 and GST-D1524-30 (open circles); or 7.5 mM RAD51 and GST-T1526A (squares).
Error bars indicate SD from at least three independent experiments.1038 Cell 136, 1032–1043, March 20, 2009 ª2009 Elsevier Inc.
Figure 7. Model Showing Regulation of RAD51-DNA Interactions by the BRC Repeats
(A) The BRC repeats promote formation of the active ATP-RAD51-ssDNA filament at several steps: (1) In the presence of Mg2+-ATP, the BRC repeats promote
binding of RAD51 to ssDNA. (2) By decreasing the rate of ATP hydrolysis, they permit accumulation of the active ATP-bound form of the filament. (3) The BRC
repeats also stabilize the ADP-RAD51-ssDNA complex, permitting exchange of ADP for ATP and further increasing accumulation of an ATP-bound nucleoprotein
filament. This filament is the active species in DNA strand exchange.
(B) The BRC repeats prevent assembly of the nonproductive ATP-RAD51-dsDNA filament: (4) The BRC repeats block nucleation of RAD51 onto dsDNA.
(C) Proposed function of the intact BRCA2 protein in DSB repair (see text for details). A break in dsDNA is resected to produce ssDNA. RPA binds to the ssDNA,
hindering RAD51 filament assembly. BRCA2 binds to the dsDNA-ssDNA junction, and loads RAD51 onto the ssDNA but blocks assembly onto the dsDNA.
RAD51 filament growth extends the BRCA2-stablized nucleus to form an ATP-bound nucleoprotein filament capable of homologous DNA pairing. Blue spheres
represent a RAD51 monomer, T represents ATP, and D represents ADP; RPA is in orange, BRCA2 is brown, and the BRC repeats are represented in purple.exchange in vitro by binding to the dsDNA target (Benson
et al., 1994; Sung and Robberson, 1995). Indeed, increasing
the RAD51 concentration to 6 mM reduced product formation
(Figure S5C, first lane), and increasing further to 7.5 mM nearly
completely blocked all product formation (Figure 6B, right panel,
lanes labeled ‘‘0’’ peptide). As predicted from our binding
studies, however, BRC4 restored product formation in a concen-
tration-dependent manner (Figures 6B, 6C, S5C, and S5D). The
effect was most dramatic at the highest RAD51 protein concen-
trations (Figures 6B and 6C), and in fact, BRC4 increased the
yield of the fully strand-exchanged DNA product (the nicked
circular dsDNA) to levels that were higher than even the optimal
reaction (at 3.75 mM RAD51 [Figures 6B and 6C]; the control
peptides, T1526A and D1524-30, had no effect in any reaction
[Figures 6B, 6C, S5A, and S5B]). Thus, these results reveal
a previously unrecognized ability of BRC4 to stimulate RAD51-
mediated DNA strand exchange.DISCUSSION
Taken together, our results show that both BRC4 alone and
BRCA2BRC1–8 can modulate RAD51 filament formation in two
mutually reinforcing ways: stimulating the assembly on ssDNA
and preventing nucleation onto dsDNA. This duality with regard
to control of RAD51 nucleoprotein filament formation is, in turn,
responsible for the regulation of RAD51-promoted DNA strand
exchange. Our results demonstrate that the interaction of the
BRC repeats with RAD51 is sufficient to enhanceRAD51 filament
assembly on ssDNA (Figure 7A, step 1). This enhancement
results from both an inhibition of ATP hydrolysis (Figure 7A,
step 2) and a stabilization of the ADP-bound form of the nucleo-
protein filament (Figure 7A, step 3). The combined consequence
is to allow exchange for ATP within the filament rather than the
dissociation of ADP-RAD51 from the ssDNA. The net effect is
maintenance of a protein filament assembled on ssDNA in itsCell 136, 1032–1043, March 20, 2009 ª2009 Elsevier Inc. 1039
ATP-bound form, which is the form that is required for DNA pair-
ing function. In addition, the BRC repeats prevent a competing
inhibitory reaction: namely, the nonfunctional assembly of
RAD51 on dsDNA (Figure 7B, step 4). The BRC repeats achieve
this function by blocking the rate-limiting nucleation of filaments
on dsDNA. The similar results obtained with a domain comprised
of the eight BRC repeats, BRCA2BRC1–8, previously shown to
stimulate RAD51-mediated DNA strand exchange (Shivji et al.,
2006), support the conclusions obtained with the single BRC4
repeat, and they further suggest that the entire BRCA2BRC1–8
domain behaves as a regulator of DNA binding, much like
BRC4. Our conclusions are also consistent with recent indepen-
dent observations on the regulation of RAD51 DNA binding by
BRCA2BRC1–8 protein (M.K.K.S., E. Rajnedra, J. Savill, and
A.R.V., unpublished data).
Crystallographic analysis defined an interaction interface
between BRC4 and RAD51 that involves the ATPase core of
RAD51 and that mimics the intermonomer interactions within
the filament (Pellegrini et al., 2002). It was found that the nucleo-
tide-binding site of RAD51 adopts a more closed conformation
when bound to BRC4, and the authors suggested that this
conformation might, in turn, alter ATP occupancy. This interpre-
tation could provide a structural explanation for the inhibition of
the ATPase activity of RAD51 by BRC4 and the resultant stabili-
zation of RAD51-ssDNA filaments if the ATP-binding pocket
closed with ATP bound and BRC4 prevented the conformational
changes needed for ATP hydrolysis.
Paradoxically, BRC repeats were also shown both to disrupt
RAD51 nucleoprotein filament formation on dsDNA and to bind
to these nucleoprotein filaments. This seemingly contradictory
outcome is likely a consequence of the two different binding
modes reported for the BRC repeats: a mode that binds
RAD51 in a monomeric state and another that binds the
nucleoprotein filament (Davies et al., 2001; Galkin et al., 2005;
Pellegrini et al., 2002); a third interaction mode, described for
the C-terminal region of BRCA2, reportedly involves oligomeric
RAD51 binding (Davies and Pellegrini, 2007; Esashi et al.,
2007). Some prior studies are seemingly contradictory to some
of the observations reported here, but our studies readily ratio-
nalize those findings. We showed that BRC4 will not inhibit
RAD51 filament formation on dsDNA, unless the RAD51 is
allowed to dissociate via ATP hydrolysis; once dissociated,
however, our studies also show that reassembly of the dissoci-
ated RAD51 protein will be blocked by BRC4, leading to an
apparent disruption of the ATP-nucleoprotein filaments. For
this reason, nucleoprotein filaments formed on dsDNA in the
presence of the nonhydrolyzable analog, AMP-PNP, are much
less affected by BRC repeats, whereas those assembled in the
presence of ATP are apparently disrupted; however, these latter
complexes are not, in fact, disrupted by the BRC repeat but,
instead, they dissociate normally and their reassembly is
blocked on a steady-state kinetic basis. In addition, BRC4 was
found to inhibit the binding of RAD51 to longer ssDNA (e.g.,
poly(dT)) (Davies and Pellegrini, 2007). However, here we discov-
ered that there are two distinct regimes of BRC4 behavior with
regard to RAD51 binding to ssDNA: stimulation at low concen-
trations of BRC4 and inhibition at high concentrations. Because
RAD51 forms unstable complexes with short oligonucleotides,1040 Cell 136, 1032–1043, March 20, 2009 ª2009 Elsevier Inc.such as dT40 or dT60, we can detect both the stimulatory regime
and the inhibitory regime (Figure 1). However, for longer ssDNA,
the binding of RAD51 is stable (close to 100% binding); thus, the
stimulatory behavior cannot be detected, and only the inhibitory
behavior is seen. This dichotomous behavior resolves the
apparent discrepancy with studies using ssDNA that forms
stable complexes with RAD51.
It was recently reported that a peptide derived from the BRC
repeat of BRCA2 can inhibit the binding of RAD51 to the fluores-
cently modified ssDNA, poly(etheno-dA) (Nomme et al., 2008);
in agreement, we observed a similar behavior with M13
etheno-ssDNA (unpublished data). We conclude that the fluores-
cent modification of these ssDNA substrates precludes the
stimulation of binding seen for BRC4with the unmodified ssDNA.
Our results show that these distinct modes of action may have
disparate consequences that depend on the type of DNA,
single- or double-stranded, involved.
When considered in conjunction with previous work that
showed that BRC repeats are necessary to target RAD51 to
ssDNA (San Filippo et al., 2006), our findings suggest that the
dominant-negative phenotype resulting from expression of
the single BRC4 in vivo (Chen et al., 1999) arises either from
the inability of an isolated repeat, without the DNA-binding
domains of BRCA2, to efficiently deliver RAD51 to the site of a
processed dsDNA break or from an inhibitory effect of excessive
BRC4 expression. Consistent with the former interpretation,
expression of a fusion of BRC4 and the ssDNA-binding domain
of a heterologous protein, RPA, restores recombinational DNA
repair in mammalian cells to nearly wild-type levels (Saeki
et al., 2006). In agreement with the latter possibility, high concen-
trations of BRC4 block DNA strand exchange in vitro (Figures
S5A and S5B).
The BRCA2 homolog from C. elegans, CeBRC2, which
possesses a single BRC repeat, was reported to reduce the
rate of ATP hydrolysis by CeRAD51 in vitro and to promote
persistent CeRAD51 nucleoprotein focus formation in vivo
(Petalcorin et al., 2007). In agreement, here we showed that
a single BRC repeat from the human BRCA2 is sufficient to
stabilize the human RAD51-ssDNA nucleoprotein complex by
decreasing ATP hydrolysis and by both stabilizing and increasing
the fraction of active ATP-bound nucleoprotein filaments on
ssDNA (Figures 2B and 2C). Collectively, the published reports
andour results support the conclusion thatBRC repeats enhance
the DNA pairing activity of RAD51 by slowing ATP hydrolysis.
Interestingly, a similar mechanism was invoked to explain the
Ca2+-dependent stabilization of the RAD51-ssDNA filament and
the consequent stimulation of DNA strand exchange (Bugreev
and Mazin, 2004). The accumulation of the ATP-bound form of
the filament by either Ca2+ or BRC4 promotes formation of an
active nucleoprotein filament on ssDNA that is necessary for
DNA strand exchange. The interaction with the BRC repeats
goes one step further: it limits the nonproductive formation of fila-
ments on dsDNA. Thus, the BRC repeats show two different
modes of interaction: one that stabilizesRAD51-ssDNAfilaments
by modulating ATPase activity and another that prevents
nucleation of filaments on dsDNA (Figures 7A and 7B).
Further research will be required to understand how the
BRC repeats and the C-terminal region orchestrate RAD51
nucleoprotein formation in the context of entire BRCA2 protein
and throughout the cell cycle. However, our observations have
revealed an unexpected dichotomy of the seemingly simple
BRC repeats in controlling RAD51 nucleoprotein filament
assembly that might be crucial for understanding the role of
BRCA2 in the DNA-damage response and repair. In Figure 7C,
we illustrate the likely function of the intact BRCA2 protein.
Duplex DNA that suffers a DSB is resected to produce ssDNA.
The ssDNA is initially bound by RPA, precluding the binding of
RAD51 and necessitating a catalyst to facilitate assembly of
RAD51 on the ssDNA (Sugiyama and Kowalczykowski, 2002).
BRCA2 is proposed to bind to the ssDNA-dsDNA junction by
virtue of its DNA-binding domain, which comprises both ssDNA-
and dsDNA-binding domains (Yang et al., 2002, 2005). The BRC
repeats recruit RAD51 to this junction and load RAD51 onto the
ssDNA, but they block its nonproductive assembly onto dsDNA.
The major role of BRCA2 is seen as nucleating the nucleoprotein
filament near the junction by preventing turnover of the nascent
nucleus of the ATP-bound RAD51 filament. Once a nascent
filament forms, growth and RPA displacement ensue, likely
aided by other mediators such as RAD52 (Benson et al., 1998;
New et al., 1998; Shinohara and Ogawa, 1998; Sung, 1997;
Sung et al., 2003).
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
See Supplemental Data.
Electrophoretic Mobility Shift Assay
The procedure was essentially as described (Galkin et al., 2005). RAD51 was
preincubated with GST-tagged BRC4, BRCA2BRC1–8, D1524–30, or T1526A
at the indicated concentrations for 15 min, followed by addition of ssDNA
(dT40, labeled with
32P at the 50 end) or dsDNA (XhoI-linearized fX174 dsDNA,
32P-labeled at the 50 end or 32P-50end labeled duplex dT40$dA40 prepared
by annealing), at the concentrations indicated, in buffer containing 20 mM
Tris-HCl (pH 7.5), 10 mM Mg(OAc)2, 2 mM CaCl2, 2 mM ATP, 100 mg/ml
BSA. The mixture was incubated for 15 min or 60 min at 37C, as indicated.
The reaction products were resolved by 6% PAGE at 4C in 13 TAE,
(40 mM Tris-acetate, pH 7.5, 0.5 mM EDTA) or using 0.5% agarose gels at
40 V o/n (in the case of fX174 dsDNA) in 13 TAE. Where indicated, ATP
was replaced with ADP or AMP-PNP (2 mM), and Mg2+ and Ca2+ were
replaced by either Mg2+ (10 mM) or Ca2+ (2 mM). The agarose gels were dried
and analyzed on a Molecular Dynamics Storm 840 PhosphorImager using
ImageQuant software. The percentage of protein-DNA complexes was quan-
tified as the free radiolabeled DNA remaining in a given lane relative to the
protein-free lane, which defined the value of 0% complex (100% free DNA).
ATP Hydrolysis Assay
RAD51 (3 mM) was preincubated with the GST-tagged BRC4, or D1524–30, at
37C for 15min, followed by addition of ssDNA (9 mMnucleotides, nt) in 10 ml of
buffer containing 20 mM TrisHCl (pH 7.5), 4 mM MgCl2, 1 mM DTT, 0.5 mM
ATP, and 20 mCi/ml [g32P]ATP, and further incubated at 37C for 1 hr. In
Figure S3, RPA (1 mM) or RPA storage buffer was preincubated with dT40
(9 mM nt) for 5 min at 37C, followed by the addition of RAD51 (3 mM) and
the concentrations specified of GST-tagged BRC4 in the same buffer as
above, and incubated at 37C for 1hr. Aliquots (1 ml) were spotted onto a poly-
ethyleneimine (PEI) thin layer chromatography (TLC) plate (EMD Chemicals).
The spots were air-dried and the plates were developed in 1 M formic acid
and 0.5 M LiCl. The amount of ATP hydrolyzed was determined from dried
plates using a Molecular Dynamics Storm 840 PhosphorImager. The amount
of 32Pi and [g
32P] ATP was quantified using ImageQuant software.Isolation and Analysis of the Nucleotide Composition of RAD51
Nucleoprotein Complexes
RAD51 (3 mM) was preincubated with the GST-tagged BRC4, or D1524–30,
at 37C for 15 min, followed by addition of ssDNA (9 mM nt), dT40, or linear
fX174 ssDNA. (The linear fX174 ssDNA was prepared by annealing an oligo-
nucleotide [80-mer] complementary to the AluI restriction site contained within
the sequence [5207–5286] of fX174 ssDNA, subsequently cutting with AluI,
and then purified using a MicroSpin S-400 HR column [Amersham].) The
protein-DNAmixture was incubated for 1 hr at 37C in 20 ml of buffer containing
20mMTrisHCl (pH 7.5), 4 mMMgCl2, 1mMDTT, 0.5 mMATP, and 6 mCi [a
32P]
ATP. Aliquots of 1 ml were spotted on PEI plates as described above. Aliquots
(19 ml) were loaded onto Micro Bio-Spin P30 columns (Bio-Rad) pre-equili-
brated in Tris-EDTA (TE [10 mM TrisHCl, pH 7.5], 1 mM EDTA), and 10 ml of
the eluate was spotted on PEI plates, air-dried, and analyzed as described
above. The amount of nucleotide bound to the isolated protein-DNA
complexes was calculated from the [a32P] ATP + [a32P] ADP content of each
lane and expressed relative to the amount of [a32P] ATP + [a32P] ADP bound
when BRC4 was absent. The ATP and ADP bound to free RAD51 was deter-
mined in parallel by doing the same experiment in the absence of DNA and
was subtracted from each lane of the experiment done in the presence of DNA.
Single-Molecule Visualization
The experimental protocol was similar to that reported previously (Bianco
et al., 2001; Galletto et al., 2006). A three-channel flow cell (4.5 mm wide
and 70 mm deep) generated three 1.5 mm laminar flow paths. Bacteriophage
l DNA, biotinylated at one end, was attached to a 1 mM streptavidin-coated
polystyrene bead (Bangs Laboratories). The bead-DNA complex in buffer
T (50 mM TrisOAc, pH 8.3, 15% sucrose, and 30 mM DTT), containing
10–20 nM YOYO-1, was trapped at a linear flow rate of 180 mm s1 at 25C.
The trapped bead-l DNA complex was then moved to the observation
channel, which contained buffer T and 5 mM Ca(OAc)2, where the YOYO-1
dissociated from the DNA in less than 1 min. The YOYO-1 allowed measure-
ment of DNA length and verification that a single DNA molecule was captured.
The bead-l DNA complex was then moved to the protein channel containing
the fluorescent RAD51 (using carboxyfluorescein succinimidyl ester coupling
to the N-terminal amino group at pH 7.0 [Galletto et al., 2006]) in buffer T con-
taining 2 mM Ca(OAc)2 with 1 mM ATP and GST-tagged BRC4, D1524–30,
or BRCA2BRC1–8 at the concentrations specified. After each incubation time,
the protein-DNA-bead complex was moved back to the second channel for
direct observation.
The dissociation experiment was conducted by forming the RAD51 nucleo-
protein filament in the protein channel in buffer T containing 1 mM ATP, 2 mM
Mg(OAc)2, and 250 nM RAD51. After 4 min of incubation, the filament was
moved to the observation channel in buffer T containing 2 mM ATP and
10 mM Mg(OAc)2, with or without 1 mM GST-BRC4. The length of the l DNA
was calculated from 11 molecules, corrected for the radius of the bead and
for extension due to the YOYO-1 dye. All the experiments were conducted
using illumination from a mercury lamp, and fluorescence was observed using
a FITC filter (Chroma Technology Corp., number 41001). Data were collected
on S-VHS tapes, digitized, and analyzed with Image J software and associated
plug-ins.
DNA Strand Exchange Assay
Reactions (20 ml) were as described (Bugreev and Mazin, 2004). RAD51 and
GST-tagged BRC4 or the control peptides D1524–30 and T1526A, at the
concentrations indicated, were incubated with fX174 ssDNA (15 mM, nt) for
5 min at 37C in buffer containing 25 mM TrisOAc, pH 7.5, 250 mM NaCl,
2 mMATP, 1mMDTT, 1 mMMgCl2, 2 mMCaCl2. RPA (1 mM) was then added,
and incubation continued for 5 min at 37C. The reaction was started by the
addition of XhoI-linearized 32P-labeled fX174 duplex DNA (15 mM, nt). After
2 hr at 37C, the samples were treated with Proteinase K (Roche) for 15 min
at 37C. Products were resolved by electrophoresis on a 1% agarose gel
(1 X TAE) at 40 V overnight. The gels were dried and analyzed on a Molecular
Dynamics Storm 840 PhosphorImager using ImageQuant software. The
amount of DNA strand exchange product at each BRC4 concentration was
calculated as a percentage of the joint molecules (JM) or nicked circular
DNA (NC) products relative to the total amount of DNA in the same lane.Cell 136, 1032–1043, March 20, 2009 ª2009 Elsevier Inc. 1041
Analysis
In all graphs, error bars represent the standard deviation derived from at least
three independent experiments and, in some cases, error bars are smaller than
the symbol; all analyses used GraphPad Prism (version 5.01).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and five
figures and can be found with this article online at http://www.cell.com/
supplemental/S0092-8674(09)00161-5.
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